United States Ependymoma Drug Market Report 2017

December 2017 | 99 pages | ID: U0A7DADDAB9EN
QYResearch

Abstracts

In this report, the United States Ependymoma Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Ependymoma Drug in these regions, from 2012 to 2022 (forecast).

United States Ependymoma Drug market competition by top manufacturers/players, with Ependymoma Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Cavion LLC
• Advantagene Inc
• Amgen Inc
• Celgene Corp
• Eli Lilly and Company
• Millennium Pharmaceuticals Inc
• NewLink Genetics Corp
• Ono Pharmaceutical Co Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Abemaciclib
• Indoximod
• Afatinib Dimaleate
• Alisertib
• G-207
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Ependymoma Drug Market Report 2017

1 EPENDYMOMA DRUG OVERVIEW

1.1 Product Overview and Scope of Ependymoma Drug
1.2 Classification of Ependymoma Drug by Product Category
  1.2.1 United States Ependymoma Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Ependymoma Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Abemaciclib
  1.2.4 Indoximod
  1.2.5 Afatinib Dimaleate
  1.2.6 Alisertib
  1.2.7 G-207
  1.2.8 Others
1.3 United States Ependymoma Drug Market by Application/End Users
  1.3.1 United States Ependymoma Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Ependymoma Drug Market by Region
  1.4.1 United States Ependymoma Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Ependymoma Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Ependymoma Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Ependymoma Drug Status and Prospect (2012-2022)
  1.4.5 New England Ependymoma Drug Status and Prospect (2012-2022)
  1.4.6 The South Ependymoma Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Ependymoma Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ependymoma Drug (2012-2022)
  1.5.1 United States Ependymoma Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Ependymoma Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES EPENDYMOMA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Ependymoma Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ependymoma Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ependymoma Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Ependymoma Drug Market Competitive Situation and Trends
  2.4.1 United States Ependymoma Drug Market Concentration Rate
  2.4.2 United States Ependymoma Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ependymoma Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES EPENDYMOMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Ependymoma Drug Sales and Market Share by Region (2012-2017)
3.2 United States Ependymoma Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Ependymoma Drug Price by Region (2012-2017)

4 UNITED STATES EPENDYMOMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Ependymoma Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ependymoma Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Ependymoma Drug Price by Type (2012-2017)
4.4 United States Ependymoma Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES EPENDYMOMA DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ependymoma Drug Sales and Market Share by Application (2012-2017)
5.2 United States Ependymoma Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES EPENDYMOMA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boehringer Ingelheim GmbH
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ependymoma Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boehringer Ingelheim GmbH Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 Ependymoma Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cavion LLC
  6.3.2 Ependymoma Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cavion LLC Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Advantagene Inc
  6.4.2 Ependymoma Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Advantagene Inc Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen Inc
  6.5.2 Ependymoma Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Inc Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celgene Corp
  6.6.2 Ependymoma Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celgene Corp Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
  6.7.2 Ependymoma Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Eli Lilly and Company Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Millennium Pharmaceuticals Inc
  6.8.2 Ependymoma Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Millennium Pharmaceuticals Inc Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 NewLink Genetics Corp
  6.9.2 Ependymoma Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 NewLink Genetics Corp Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Ono Pharmaceutical Co Ltd
  6.10.2 Ependymoma Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Ono Pharmaceutical Co Ltd Ependymoma Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 EPENDYMOMA DRUG MANUFACTURING COST ANALYSIS

7.1 Ependymoma Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ependymoma Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ependymoma Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ependymoma Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES EPENDYMOMA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Ependymoma Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ependymoma Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Ependymoma Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Ependymoma Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ependymoma Drug
Figure United States Ependymoma Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Ependymoma Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Abemaciclib Product Picture
Figure Indoximod Product Picture
Figure Afatinib Dimaleate Product Picture
Figure Alisertib Product Picture
Figure G-207 Product Picture
Figure Others Product Picture
Figure United States Ependymoma Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Ependymoma Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Ependymoma Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ependymoma Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Ependymoma Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ependymoma Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Ependymoma Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Ependymoma Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ependymoma Drug Sales Share by Players/Suppliers
Figure 2017 United States Ependymoma Drug Sales Share by Players/Suppliers
Figure United States Ependymoma Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ependymoma Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ependymoma Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ependymoma Drug Revenue Share by Players/Suppliers
Figure 2017 United States Ependymoma Drug Revenue Share by Players/Suppliers
Table United States Market Ependymoma Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Ependymoma Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Ependymoma Drug Market Share of Top 3 Players/Suppliers
Figure United States Ependymoma Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ependymoma Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ependymoma Drug Product Category
Table United States Ependymoma Drug Sales (K Pcs) by Region (2012-2017)
Table United States Ependymoma Drug Sales Share by Region (2012-2017)
Figure United States Ependymoma Drug Sales Share by Region (2012-2017)
Figure United States Ependymoma Drug Sales Market Share by Region in 2016
Table United States Ependymoma Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ependymoma Drug Revenue Share by Region (2012-2017)
Figure United States Ependymoma Drug Revenue Market Share by Region (2012-2017)
Figure United States Ependymoma Drug Revenue Market Share by Region in 2016
Table United States Ependymoma Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Ependymoma Drug Sales (K Pcs) by Type (2012-2017)
Table United States Ependymoma Drug Sales Share by Type (2012-2017)
Figure United States Ependymoma Drug Sales Share by Type (2012-2017)
Figure United States Ependymoma Drug Sales Market Share by Type in 2016
Table United States Ependymoma Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ependymoma Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ependymoma Drug by Type (2012-2017)
Figure Revenue Market Share of Ependymoma Drug by Type in 2016
Table United States Ependymoma Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Ependymoma Drug Sales Growth Rate by Type (2012-2017)
Table United States Ependymoma Drug Sales (K Pcs) by Application (2012-2017)
Table United States Ependymoma Drug Sales Market Share by Application (2012-2017)
Figure United States Ependymoma Drug Sales Market Share by Application (2012-2017)
Figure United States Ependymoma Drug Sales Market Share by Application in 2016
Table United States Ependymoma Drug Sales Growth Rate by Application (2012-2017)
Figure United States Ependymoma Drug Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Cavion LLC Basic Information List
Table Cavion LLC Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cavion LLC Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Cavion LLC Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Cavion LLC Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Advantagene Inc Basic Information List
Table Advantagene Inc Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advantagene Inc Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Advantagene Inc Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Advantagene Inc Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Amgen Inc Basic Information List
Table Amgen Inc Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Amgen Inc Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Amgen Inc Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Celgene Corp Basic Information List
Table Celgene Corp Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corp Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Celgene Corp Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Celgene Corp Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Millennium Pharmaceuticals Inc Basic Information List
Table Millennium Pharmaceuticals Inc Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Millennium Pharmaceuticals Inc Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals Inc Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Millennium Pharmaceuticals Inc Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table NewLink Genetics Corp Basic Information List
Table NewLink Genetics Corp Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure NewLink Genetics Corp Ependymoma Drug Sales Growth Rate (2012-2017)
Figure NewLink Genetics Corp Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure NewLink Genetics Corp Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Ono Pharmaceutical Co Ltd Basic Information List
Table Ono Pharmaceutical Co Ltd Ependymoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ono Pharmaceutical Co Ltd Ependymoma Drug Sales Growth Rate (2012-2017)
Figure Ono Pharmaceutical Co Ltd Ependymoma Drug Sales Market Share in United States (2012-2017)
Figure Ono Pharmaceutical Co Ltd Ependymoma Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ependymoma Drug
Figure Manufacturing Process Analysis of Ependymoma Drug
Figure Ependymoma Drug Industrial Chain Analysis
Table Raw Materials Sources of Ependymoma Drug Major Players/Suppliers in 2016
Table Major Buyers of Ependymoma Drug
Table Distributors/Traders List
Figure United States Ependymoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Ependymoma Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ependymoma Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Ependymoma Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Ependymoma Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ependymoma Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ependymoma Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources